Schlagwort: funding
It’s time to focus on cardiovascular diseases!
To no one’s surprise, the oncology sector dominates the top deals in biopharma year by year. The industry simply ‘knows’ how to develop novel...
How to access the public US capital market without an IPO?
European medtech and biotech companies might find engaging in a reverse merger (RM) with a US-based Nasdaq-listed company to be an appealing alternative to...